SUBSCRIBE
SUBSCRIBE

Sapience Therapeutics, Inc.

NEWS
Drug Development
Sapience, Intensity, Kazia and Transcenta Tout Early Success at ASCO
Four life sciences companies posted previews of their respective programs ahead of the American Society of Clinical Oncology (ASCO) annual meeting on June 5, 2022.
June 3, 2022
 · 
3 min read
 · 
Vanessa Doctor, RN
Courtesy of Getty Images
Drug Development
Money on the Move: Sapience Scores $41m Backed by BMS, NexPoint
Most money moves happened in Europe this week, including a government-backed award for Parkinson’s disease research and seed funding for an RNA platform.
June 2, 2022
 · 
4 min read
 · 
Hannah Chudleigh
JOBS
IN THE PRESS
Drug Development
Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
June 1, 2024
 · 
5 min read
Pharm Country
Sapience Therapeutics Announces Late-Breaking Research Poster Presentations on ST101 and ST316 at the American Association for Cancer Research (AACR) Annual Meeting 2023
March 16, 2023
 · 
5 min read
Drug Development
Sapience Therapeutics Receives IND Clearance from FDA to Proceed with Phase 1-2 Study of ST316 in Patients with Solid Tumors
March 14, 2023
 · 
5 min read
Pharm Country
Sapience Therapeutics to Present at the Guggenheim Healthcare Talks 2023 Oncology Day
January 26, 2023
 · 
2 min read
Drug Development
Sapience Therapeutics Commences Dosing in Final Dose-Escalation Cohort of Ongoing Phase 1-2 Study of ST101
July 29, 2021
 · 
5 min read
Business
Sapience Therapeutics to Participate at SVB Leerink Biopharma Private Company Connect
July 15, 2021
 · 
2 min read
Pharm Country
Sapience Therapeutics to Present at BIO Digital 2021
June 9, 2021
 · 
4 min read
Business
Sapience Therapeutics Enters Into Collaboration with National Cancer Institute (NCI) to Study ST101 Response in Specialized Tumor Models
May 27, 2021
 · 
4 min read
Drug Development
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases
May 18, 2021
 · 
3 min read
Pharm Country
Sapience Therapeutics Announces Multiple Posters, Including Late-Breaker, at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 6, 2021
 · 
4 min read
Load More